Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CAMLG Antikörper (N-Term)

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch CAMLG in WB. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN630925

Kurzübersicht für CAMLG Antikörper (N-Term) (ABIN630925)

Target

Alle CAMLG Antikörper anzeigen
CAMLG (Calcium Modulating Ligand (CAMLG))

Reaktivität

  • 31
  • 9
  • 9
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
Human

Wirt

  • 30
  • 7
  • 1
Kaninchen

Klonalität

  • 34
  • 4
Polyklonal

Konjugat

  • 29
  • 3
  • 2
  • 2
  • 1
  • 1
Dieser CAMLG Antikörper ist unkonjugiert

Applikation

  • 34
  • 15
  • 11
  • 10
  • 9
  • 8
  • 5
  • 1
Western Blotting (WB)
  • Bindungsspezifität

    • 7
    • 6
    • 4
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term

    Spezifität

    CAMLG antibody was raised against the N terminal of CAMLG

    Aufreinigung

    Affinity purified

    Immunogen

    CAMLG antibody was raised using the N terminal of CAMLG corresponding to a region with amino acids LLMNSEQRINRIMGFHRPGSGAEEESQTKSKQQDSDKLNSLSVPSVSKRV
  • Applikationshinweise

    WB: 1 µg/mL
    Optimal conditions should be determined by the investigator.

    Kommentare

    CAMLG Blocking Peptide, (ABIN5612597), is also available for use as a blocking control in assays to test for specificity of this CAMLG antibody

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Lyophilized powder. Add distilled water for a 1 mg/mL concentration of CAMLG antibody in PBS

    Konzentration

    Lot specific

    Buffer

    PBS

    Handhabung

    Avoid repeated freeze/thaw cycles.
    Dilute only prior to immediate use.

    Lagerung

    4 °C/-20 °C

    Informationen zur Lagerung

    Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
  • Target

    CAMLG (Calcium Modulating Ligand (CAMLG))

    Andere Bezeichnung

    CAMLG

    Hintergrund

    The immunosuppressant drug cyclosporin A blocks a calcium-dependent signal from the T-cell receptor (TCR) that normally leads to T-cell activation. When bound to cyclophilin B, cyclosporin A binds and inactivates the key signaling intermediate calcineurin. CAMLG functions similarly to cyclosporin A, binding to cyclophilin B and acting downstream of the TCR and upstream of calcineurin by causing an influx of calcium. This integral membrane protein appears to be a new participant in the calcium signal transduction pathway, implicating cyclophilin B in calcium signaling, even in the absence of cyclosporin.

    Molekulargewicht

    33 kDa (MW of target protein)

    Pathways

    EGFR Signaling Pathway
Sie sind hier:
Chat with us!